Clinical Trial Update: Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating MEDI5752 in combination with stereotactic radiotherapy for metastatic soft tissue sarcoma; the trial is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• MEDI5752

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Soft Tissue Sarcoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING